- Home
- RAYA vs CCEL Comparison
RAYA vs CCEL Comparison
Compare RAYA & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAYA
- CCEL
- Stock Information
- Founded
- RAYA 2019
- CCEL 1989
- Country
- RAYA China
- CCEL United States
- Employees
- RAYA N/A
- CCEL N/A
- Industry
- RAYA Metal Fabrications
- CCEL Managed Health Care
- Sector
- RAYA Consumer Discretionary
- CCEL Health Care
- Exchange
- RAYA Nasdaq
- CCEL Nasdaq
- Market Cap
- RAYA 34.2M
- CCEL 39.9M
- IPO Year
- RAYA 2022
- CCEL 1997
- Fundamental
- Price
- RAYA $2.00
- CCEL $5.13
- Analyst Decision
- RAYA
- CCEL Strong Buy
- Analyst Count
- RAYA 0
- CCEL 1
- Target Price
- RAYA N/A
- CCEL $8.50
- AVG Volume (30 Days)
- RAYA 60.1K
- CCEL 8.3K
- Earning Date
- RAYA 01-01-0001
- CCEL 07-14-2025
- Dividend Yield
- RAYA N/A
- CCEL 7.97%
- EPS Growth
- RAYA N/A
- CCEL N/A
- EPS
- RAYA N/A
- CCEL 0.01
- Revenue
- RAYA $30,300,360.00
- CCEL $32,102,750.00
- Revenue This Year
- RAYA $20.95
- CCEL $2.49
- Revenue Next Year
- RAYA N/A
- CCEL $0.95
- P/E Ratio
- RAYA N/A
- CCEL $555.99
- Revenue Growth
- RAYA 49.10
- CCEL 2.33
- 52 Week Low
- RAYA $0.56
- CCEL $4.75
- 52 Week High
- RAYA $2.47
- CCEL $9.43
- Technical
- Relative Strength Index (RSI)
- RAYA 66.34
- CCEL 50.16
- Support Level
- RAYA $2.02
- CCEL $5.00
- Resistance Level
- RAYA $2.38
- CCEL $5.31
- Average True Range (ATR)
- RAYA 0.22
- CCEL 0.22
- MACD
- RAYA 0.03
- CCEL 0.02
- Stochastic Oscillator
- RAYA 59.80
- CCEL 43.09
About RAYA Erayak Power Solution Group Inc.
Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from three products namely inverters, chargers, and gasoline generators. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.